Morgan Stanley Cbd Md, Inc. Transaction History

Morgan Stanley

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.16 - $0.34 $0 - $0	-1 Reduced 0.03%	3,250 $0
Q4 2022 Feb 14, 2023	SELL	$0.22 - $15.3 $110 - $7,665	-501 Reduced 13.35%	3,251 $0
Q3 2022 Nov 14, 2022	SELL	$0.0 - $21.78 $0 - $21,845	-1,003 Reduced 21.09%	3,752 $1,000
Q2 2022 Oct 27, 2022	SELL	$0.0 - $0.0 $0 - $0	-5,489 Reduced 53.58%	4,755 $2,000
Q2 2022 Aug 15, 2022	SELL	$0.0 - $0.0 $0 - $0	-5,489 Reduced 53.58%	4,755 $2,000
Q1 2022 Oct 27, 2022	BUY	$0.0 - $0.0 $0 - $0	5,489 Added 115.44%	10,244 $11,000
Q1 2022 May 13, 2022	SELL	$0.0 - $0.0 $0 - $0	-843 Reduced 7.6%	10,244 $11,000
Q4 2021 Feb 14, 2022	SELL	$0.0 - $6.95 $0 - $192,403	-27,684 Reduced 71.4%	11,087 $12,000
Q3 2021 Nov 15, 2021	BUY	$0.0 - $7.49 $0 - $290,394	38,771 New	38,771 $80,000

125K

Ticker YCBD
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 60,555,600
Market Cap $26.6M
Description
cbdMD, Inc. produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, bath bombs, bath salts, and sleep aids. It also offers veterinarian-formulated products, ...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.